Studies genes linked to problems after heart surgery
Looks for genetic causes of complications, such as atrial fibrillation, after heart surgery.
Plain-language title generated from the registry record
Registry title: Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Key facts
- Where
- Boston, Dallas, and Houston, United StatesSee the 3 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 90 years old?
Source: NCT01258231, who can take part
Where in United States
- Brigham and Women's HospitalBoston, United StatesNo longer taking part
- UT Southwestern Medical CenterDallas, United StatesTaking people
- Department Texas Heart Institute at St. Luke's Episcopal HospitalHouston, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Brigham and Women's Hospital
- Trial code
- NCT01258231
- Record updated
- 22 August 2024
- Original description
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.Read full original descriptionShow less
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.
Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
Inclusion: Undergoing heart surgery; Willing to provide consent.
Exclusion: Enrolled in a concurrent drug or device trial that precludes concurrent enrollment.